SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003153
Filing Date
2014-05-12
Accepted
2014-05-12 16:53:46
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0314_actinium.htm 10-Q 635495
2 SUBLEASE AGREEMENT f10q0314ex10i_actinium.htm EX-10.1 106013
3 CERTIFICATION f10q0314ex31i_actinium.htm EX-31.1 18782
4 CERTIFICATION f10q0314ex32i_actinium.htm EX-32.1 8010
  Complete submission text file 0001213900-14-003153.txt   5149295

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT atnm-20140331.xml EX-101.INS 643958
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atnm-20140331.xsd EX-101.SCH 63256
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atnm-20140331_cal.xml EX-101.CAL 24169
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atnm-20140331_def.xml EX-101.DEF 221236
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT atnm-20140331_lab.xml EX-101.LAB 492927
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atnm-20140331_pre.xml EX-101.PRE 320985
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 14834050
SIC: 6770 Blank Checks